iRhythm Technologies, Inc.

Informe acción NasdaqGS:IRTC

Capitalización de mercado: US$3.2b

iRhythm Technologies Dirección

Dirección controles de criterios 1/4

El CEO de iRhythm Technologies' es Quentin Blackford , nombrado en Oct 2021, tiene una permanencia de 2.5 años. compensación anual total es $16.60M, compuesta por 4.1% salario y 95.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.23% de las acciones de la empresa, por valor de $8.04M. La antigüedad media del equipo directivo y de la junta directiva es de 1.9 años y 6.8 años, respectivamente.

Información clave

Quentin Blackford

Chief Executive Officer (CEO)

US$16.6m

Compensación total

Porcentaje del salario del CEO4.1%
Permanencia del CEO2.6yrs
Participación del CEO0.2%
Permanencia media de la dirección1.9yrs
Promedio de permanencia en la Junta Directiva6.8yrs

Actualizaciones recientes de la dirección

Recent updates

iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't

Mar 25
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't

Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

Feb 25
Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?

Feb 02
iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate

Dec 20
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate

iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Dec 20
iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Dec 02
Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

Sep 20
Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate

Aug 30
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate

When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Jul 04
When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Jun 16
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

May 26
Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark

May 08
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark

What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?

Mar 27
What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?

Feb 25
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?

Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

Nov 24
Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

iRhythm falls after reaffirming 2022 guidance

Sep 21

iRhythm: Fairly Priced At Current Multiples, No Need To Size Up

Sep 02

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Aug 18
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

iRhythm Technologies Q2 results beat estimates, co raises FY 2022 revenue guidance

Aug 04

iRhythm Technologies provides FY22 prelims, commercial chief resigns

Jul 19

iRhythm: Reimbursement Overhang Squashed, Bull Thesis Back Intact

Jun 08

Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?

Apr 14
Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Quentin Blackford en comparación con los beneficios de iRhythm Technologies?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2024n/an/a

-US$130m

Dec 31 2023US$17mUS$677k

-US$123m

Sep 30 2023n/an/a

-US$105m

Jun 30 2023n/an/a

-US$99m

Mar 31 2023n/an/a

-US$105m

Dec 31 2022US$8mUS$650k

-US$116m

Sep 30 2022n/an/a

-US$128m

Jun 30 2022n/an/a

-US$131m

Mar 31 2022n/an/a

-US$124m

Dec 31 2021US$10mUS$163k

-US$101m

Compensación vs. Mercado: La compensación total de Quentin($USD16.60M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD6.59M).

Compensación vs. Ingresos: La compensación de Quentin ha aumentado mientras la empresa no es rentable.


CEO

Quentin Blackford (44 yo)

2.6yrs

Permanencia

US$16,595,149

Compensación

Mr. Quentin S. Blackford serves as an Independent Director of Paragon 28, Inc. since August 1, 2022. He serves as President and Chief Executive Officer since October 04, 2021 and serves as Director at iRhy...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Quentin Blackford
President2.6yrsUS$16.60m0.23%
$ 7.4m
Brice Bobzien
Chief Financial Officer1.8yrsUS$5.28m0.0085%
$ 272.1k
Minang Turakhia
Chief Medical & Scientific Officer and Executive VP of Product Innovation2.1yrsUS$5.32m0.011%
$ 356.4k
Patrick Murphy
Chief Business & Legal Officer2.4yrsUS$5.33m0.031%
$ 980.2k
Chad Patterson
Chief Commercial Officer1.8yrsUS$5.77m0.017%
$ 547.1k
Mervin Smith
Executive Vice President of Business Operationsless than a yearsin datossin datos
Marc Rosenbaum
Senior VP of Finance & Chief Accounting Officerless than a yearsin datossin datos
Daniel Wilson
Executive VP of Corporate Development & Investor Relations4.9yrsUS$3.54m0.098%
$ 3.1m
Douglas Devine
Executive Advisor1.2yrsUS$2.72m0.055%
$ 1.8m
Sumi Shrishrimal
Executive VP & Chief Risk Officer2yrssin datos0.079%
$ 2.5m
Stephanie Zhadkevich
Director of Investor Relationsno datasin datossin datos

1.9yrs

Permanencia media

44yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de IRTC no se considera experimentado ( 1.9 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Quentin Blackford
President2.3yrsUS$16.60m0.23%
$ 7.4m
Ralph Snyderman
Independent Director6.8yrsUS$233.12k0.028%
$ 892.0k
Michael Mirro
Medical Director & Member of Scientific Advisory Boardno datasin datossin datos
Bruce Bodaken
Independent Director6.8yrsUS$240.25k0.026%
$ 825.3k
Abhijit Talwalkar
Independent Chairman8yrsUS$286.74k0.029%
$ 927.8k
R. Mead
Medical Director & Member of Scientific Advisory Boardno datasin datossin datos
James Quinn
Member of Scientific Advisory Boardno datasin datossin datos
Cathleen Noel Merz
Independent Director6.1yrsUS$230.62k0.014%
$ 449.4k
Mark Rubash
Independent Director8.2yrsUS$227.70k0.030%
$ 943.5k
Mehdi Razavi
Medical Director & Member of Scientific Advisory Boardno datasin datossin datos
Karen Ling
Independent Director2.5yrsUS$239.97k0.011%
$ 362.5k
Jay Alexander
Medical Director & Member of Scientific Advisory Boardno datasin datossin datos

6.8yrs

Permanencia media

66yo

Promedio de edad

Junta con experiencia: La junta directiva de IRTC se considera experimentada (6.8 años de antigüedad promedio).